You are here: Industry Insights > hypertension

News List

Research Progress on the Mechanism of Hypertension and New Drug Development Xiaomichong
July 08, 2024
October 8th of every year is National Hypertension Day. Hypertension is a cardiovascular syndrome with elevated arterial pressure as its main clinical manifestation.
Ambrisentan API Price and Manufacturers in China PharmaSources.com
October 22, 2021
Ambrisentan is a type A endothelin receptor antagonist that is taken orally. It is used to treat pulmonary arterial hypertension. It is authorized as a single medication in the United States and Europe...
New Track: Japanese Digital Therapeutics for Hypertension Achieves Success in Phase III Clinical Trial PharmaSources/Xiaoyaowan
April 07, 2021
The Japanese company CureApp has recently announced the results of a Phase III multicenter randomized controlled clinical trial of their digital therapeutics for hypertension, which was jointly researched by CureApp and a team led ...
Metavention Completes U.S. Enrollment in Groundbreaking Feasibility Study to Treat Type 2 Diabetes prnasia
January 06, 2022
Metavention, Inc. announces the completion of enrollment in the DeLIVER U.S. Study (NCT04285554), to evaluate the safety of sympathetic denervation of the liver using its new Integrated Radio Frequency (iRF) Denervation System.
China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval prnasia
August 05, 2021
China Pharma Holdings, Inc., a specialty pharmaceutical company, today announced that its Candesartan hypertension product passed key bioequivalence tests. The Company plans to use the results of the key benchmark tests of consistency evaluation to ...
Hypertension: study suggests ARBs should be used before ACE inhibitors pharmaceutical-technology
July 29, 2021
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are both recommended, first-line treatments for hypertension, or high blood pressure.
Controlled BP Down Among U.S. Adults With HTN After 2013–2014 drugs.com
September 24, 2020
The prevalence of controlled blood pressure (BP) among U.S. adults with hypertension increased from 1999-2000 to 2007-2008 then decreased after 2013 to 2014, according to a study published online Sept. 9 in the Journal of the American Medical Association.
Glenmark launches hypertension awareness symbol, endorsed by API and HSI expresspharma
July 20, 2020
Glenmark Pharmaceuticals has launched the world’s first hypertension awareness symbol, in collaboration with the Association of Physicians of India (API) and Hypertension Society of India (HSI).
Popular blood pressure medicines do not put patients at greater COVID-19 risk, new study finds expresspharma
June 16, 2020
Two blood pressure-lowering drug classes, called ACE inhibitors and ARBs, came under scrutiny after the US Centers for Disease Control and Prevention reported in April that 72 per cent of hospitalized COVID-19 patients 65 or older had hypertension.
Adding natural extracts to medicine formulation improves hypertension drugs europeanpharmaceuticalreview
March 11, 2020
A study has demonstrated that adding certain natural extracts into hypertension drug formulation aids in supporting cardiovascular function.

Previous page 1 2 3 Next page